2025 Exhibitor Prospectus
Read AIM’s 2025 Exhibitor Prospectus for more information on the AIM Alliance program and exhibiting opportunities and benefits.
AIM Policy Summary: April 22, 2022
Legislation related to school requirements and mandates progressed in four states. Read up on the latest legislation in jurisdictions compiled by AIM staff.
Economic Analysis of Implementing Five Strategies for Increasing COVID-19 Pediatric Vaccine Coverage
This AIM poster was displayed at the CDC 2024 NIC and was about the economic analysis of AIM’s Promising Practices for Increasing COVID-19 Pediatric Vaccine Coverage Rates toolkit.
2024 Adult Vaccine Access Cooperative (VAC) Meetings Final Report
This report is a detailed overview of the 2024 Adult Vaccine Access Cooperative (VAC) meetings.
AIM Policy Summary: April 29, 2022
Legislation was enacted in five states this week regarding COVID-19, mandates, and exemptions. Read up on the latest legislation in jurisdictions compiled by AIM staff.
Vaccine Access Cooperative
This report is a detailed overview of the 2024 Adult Vaccine Access Cooperative (VAC) meetings. AIM convened eight regional VAC meetings from May through July 2024 to focus on improving…
Request for Interest Forms: Community of Practice to Optimize Administration of Birth Dose Immunizations
AIM invites participation in its Immunization Program and Birthing Institution Community of Practice (CoP) to Optimize Administration of Birth Dose Immunizations.
ASTHO Congressional Briefing Remarks
Consistent and accurate vaccine allocations and projections are needed for planning, and strong communication with the public about what is happening and what they can expect.
South Dakota: Coalition Partnership to Increase Education Opportunities
The South Dakota immunization program and Immunize South Dakota formalized a partnership to better support each other’s work and expand both programs’ capacity.
2025-2026 Respiratory Syncytial Virus (RSV) Monoclonal Antibody (mAb) Season Extension Map
The AIM RSV Season Extension Map provides a national snapshot of how the 66 federally funded immunization programs are responding to recent increases in RSV cases.